C
Celldex Therapeutics, Inc.
CLDX · NASDAQ · Healthcare · 2.8B
Closing price
$29.89
+2.01% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
3.8×
Enterprise value / EBITDAEV/EBITDA
-7.7×
Free cash flow yieldFCF yield
-10.7%
Return on equityROE
-49.1%
Operating margin
-19160.0%
Net debt / EBITDAbalance-sheet strength
0.1×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.